GL1X · GenesisL1 explorer

MolNFT v1 · #98334 · protein

Crystal structure of human mitochondrial deoxyribonucleotidase in complex with the inhibitor pib-T

4L6C · 5'(3')-deoxyribonucleotidase, mitochondrial: “Crystal structure of human mitochondrial deoxyribonucleotidase in complex with the inhibitor pib-T”. X-ray diffraction, 3 ligands (0BT, MG, PO4), 2 pockets (best druggability 0.71).…

PDB
4L6C
Type
protein
Length
201 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
5'(3')-deoxyribonucleotidase, mitochondrial
EC
3.1.3.-
UniProt
Q9NPB1
Ligands
0BT, MG, PO4
Pockets
2 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A5'(3')-deoxyribonucleotidase, mitochondrial (EC 3.1.3.-)protein20134% helix, 15% strandQ9NPB1

Ligands and binding sites

  • 0BT · 1-{2-deoxy-3,5-O-[(4-iodophenyl)(phosphono)methylidene]-beta-D-threo-pentofuranosyl}-5-methylpyrimidine-2,4(1H,3H)-dione · ligand · chains A
  • MG · Magnesium ion · metal · chains A
  • PO4 · Phosphate ion · ion · chains A
  • GOL · Glycerol · additive · 7 copies · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13090.710.8432PO4, 0BT
2800.330.7419GOL

Compared structures

  • 4L6C · Crystal structure of human mitochondrial deoxyribonucleotidase in complex with the… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9NPB1 · AlphaFold monomer V2.0 prediction for 5'(3')-deoxyribonucleotidase, mitochondrial (Q9NPB1) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.